Literature DB >> 7067310

Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods.

A Tamsen, P Hartvig, C Fagerlund, B Dahlström.   

Abstract

The influence of anaesthesia and surgery on the pharmacokinetics of pethidine (meperidine) was studied in 12 patients. Plasma pethidine concentrations in central venous blood collected during anaesthesia and the ensuing postoperative hours were by gas chromatography with electron capture detection. Postoperative analgesia was accomplished by patient-controlled intravenous administration of small doses of pethidine. The NONLIN program was used to calculate pharmacokinetic parameters for each individual. A single dose study of pethidine kinetics was carried out in all patients 3 to 5 days postoperatively. Mean +/- SD for peroperative Vd area was 4.3 +/- 1.7L/kg and for the elimination half-life was 6.1 +/- 3.6h. In the postoperative period Vdarea was 3.2 +/- 0.8L/kg and the elimination half-life was 3.2 +/- 1.4h. Plasma clearance increased from a peroperative value of 8.9 +/- 1.9 ml/min/kg to a postoperative value of 12 +/- 3.0 ml/min/kg. The changes in elimination half-life and plasma clearance are significant. The postoperative pharmacokinetics of pethidine were in accordance with those reported for healthy volunteers. The fraction of unbound pethidine was significantly reduced postoperatively - from 0.26 +/- 0.10 (peroperatively) to 0.18 +/- 0.10 (3 to 5 days later).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067310     DOI: 10.2165/00003088-198207020-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  54 in total

1.  Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents.

Authors:  G T Tucker; L E Mather
Journal:  Br J Anaesth       Date:  1975-02       Impact factor: 9.166

2.  The clinical pharmacology of meperidine--comparison of routes of administration.

Authors:  J E Stambaugh; I W Wainer; J K Sanstead; D M Hemphill
Journal:  J Clin Pharmacol       Date:  1976 May-Jun       Impact factor: 3.126

3.  Endocrine control of plasma protein and volume.

Authors:  D S Gann
Journal:  Surg Clin North Am       Date:  1976-10       Impact factor: 2.741

4.  Systemic availability of orally administered meperidine.

Authors:  L E Mather; G T Tucker
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

5.  Impaired elimination of meperidine in patients with liver disease.

Authors:  T S McHorse; U Klotz; G Wilkinson; S Schenker
Journal:  Trans Assoc Am Physicians       Date:  1974

6.  Pharmacokinetics of high-dose meperidine in surgical patients.

Authors:  A J Koska; W G Kramer; A Romagnoli; A S Keats; P B Sabawala
Journal:  Anesth Analg       Date:  1981-01       Impact factor: 5.108

7.  Disposition of meperidine in pregnancy.

Authors:  D Morgan; G Moore; J Thomas; E Triggs
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

8.  Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

9.  The physiological disposition and fate of meperidine (demerol) in man and a method for its estimation in plasma.

Authors:  J J BURNS; B L BERGER; P A LIEF; A WOLLACK; E M PAPPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-07       Impact factor: 4.030

10.  Influence of surgery on plasma propranolol levels and protein binding.

Authors:  J Feely; A Forrest; A Gunn; W Hamilton; I Stevenson; J Crooks
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

View more
  11 in total

Review 1.  Pharmacokinetic optimisation of opioid treatment in acute pain therapy.

Authors:  R N Upton; T J Semple; P E Macintyre
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of pethidine: 1982.

Authors:  D J Edwards; C K Svensson; J P Visco; D Lalka
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

3.  Pulmonary disposition of pethidine in postoperative patients.

Authors:  M P Persson; P Hartvig; L Wiklund; L Paalzow
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

5.  Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

6.  Patient-controlled analgesic therapy, Part III: pharmacokinetics and analgesic plasma concentrations of ketobemidone.

Authors:  A Tamsen; U Bondesson; B Dahlström; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

7.  Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.

Authors:  B Dahlström; A Tamsen; L Paalzow; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

Review 8.  Newer methods of delivery of opiates for relief of pain.

Authors:  P J Slattery; R A Boas
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

9.  Extradural and parenteral pethidine as analgesia after total hip replacement: effects and kinetics. A controlled clinical study.

Authors:  L L Gustafsson; J Johannisson; M Garle
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Changes in milk composition associated with pethidine-PCEA usage after Caesarean section.

Authors:  Wan Jun Tie; Hazel Gardner; Ching Tat Lai; Anna Rachel Hepworth; Yasir Al-Tamimi; Michael James Paech; Peter Edwin Hartmann; Donna Tracy Geddes
Journal:  Matern Child Nutr       Date:  2016-04-04       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.